Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kofol
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Kofol is a proprietary Ayurvedic herbal formulation developed by Charak Pharma to provide relief from cough, sore throat, and respiratory congestion. It is available in multiple dosage forms, including chewable tablets, syrups, and lozenges. The formulation contains a synergistic blend of traditional Ayurvedic herbs, such as Yashtimadhu (Glycyrrhiza glabra), Shunthi (Zingiber officinale), Bibhitaki (Terminalia bellirica), Tulsi (Ocimum sanctum), and Vasa (Adhatoda vasica). These ingredients work together to soothe throat irritation, reduce inflammation, liquefy mucus, and suppress cough reflexes. Kofol is non-drowsy and is suitable for both dry and productive coughs of allergic or infective origin.
- Brand names
- Kofol
- Other names
- Kofol Chewable TabletKofol Chewable TabletsKofol Syrup
Beyond the preview
Go deeper on Kofol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kofol.